Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,360 | 1,190 | -12,080 | -9,350 | -7,050 |
| Depreciation Amortization | 2,960 | 1,470 | 7,240 | 5,530 | 3,790 |
| Other Working Capital | 9,310 | 4,720 | -9,270 | -5,560 | -8,170 |
| Other Operating Activity | 1,980 | 560 | 6,610 | 4,560 | 3,480 |
| Operating Cash Flow | $11,890 | $7,940 | $-7,500 | $-4,820 | $-7,950 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -970 | -410 | -3,520 | -3,430 | -1,620 |
| Other Investing Activity | -26,040 | -11,310 | 4,430 | 10,810 | 4,070 |
| Investing Cash Flow | $-27,010 | $-11,720 | $910 | $7,380 | $2,450 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -4,020 | -4,040 | 8,880 | 450 | 170 |
| Financing Cash Flow | $-4,020 | $-4,040 | $8,880 | $450 | $170 |
| Exchange Rate Effect | -670 | -1,340 | -1,570 | -920 | 1,720 |
| Beginning Cash Position | 27,020 | 27,020 | 26,310 | 26,310 | 26,310 |
| End Cash Position | 7,200 | 17,850 | 27,020 | 28,400 | 22,700 |
| Net Cash Flow | $-19,810 | $-9,160 | $700 | $2,090 | $-3,610 |
| Free Cash Flow | |||||
| Operating Cash Flow | 11,890 | 7,940 | -7,500 | -4,820 | -7,950 |
| Free Cash Flow | 11,890 | 7,940 | -7,500 | -4,820 | -7,950 |